Biotech · Private company
Kumquat Biosciences Inc.
Track this companyFree. Adds Kumquat Biosciences Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials77 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- Imatinib (Gleevec)Phase 2 · GIST - Gastrointestinal Stromal TumorClinicalTrials.gov · fetched Nov 12, 2026
- KQB198Phase 2 · GIST - Gastrointestinal Stromal TumorClinicalTrials.gov · fetched Nov 12, 2026
- AmivantamabPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- CetuximabPhase 1 · KRAS G12C MutationClinicalTrials.gov · fetched Nov 12, 2026
- DasatinibPhase 1 · Hematologic MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- KQB168Phase 1 · Solid Tumor MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- KQB198Phase 1 · KRAS G12C MutationClinicalTrials.gov · fetched Nov 12, 2026
- KQB198Phase 1 · Hematologic MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- KQB198Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- KQB365Phase 1 · KRAS G12C MutationClinicalTrials.gov · fetched Nov 12, 2026
- KQB368Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- KQB548Phase 1 · Solid Tumor MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- OsimertinibPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Solid Tumor MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)PHASE2 · RECRUITING · started Jun 23, 2026ClinicalTrials.gov NCT07406633 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid MalignanciesPHASE1 · RECRUITING · started May 27, 2026ClinicalTrials.gov NCT07542704 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid MalignanciesPHASE1 · RECRUITING · started Sep 16, 2025ClinicalTrials.gov NCT07207707 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesPHASE1 · RECRUITING · started Jun 24, 2025ClinicalTrials.gov NCT06994806 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesPHASE1 · RECRUITING · started Feb 4, 2025ClinicalTrials.gov NCT06720987 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic MalignanciesPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 9, 2024ClinicalTrials.gov NCT06645886 · fetched Nov 12, 2026
- A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 3, 2024ClinicalTrials.gov NCT06507306 · fetched Nov 12, 2026